Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1

Conditions

Multiple Myeloma 3Recurrence 1Neoplasms, Plasma Cell 1Myelodysplastic Syndromes 1Motor Activity 1Leukemia, Myeloid, Acute 1Leukemia 1Hematologic Diseases 1Graft vs Host Disease 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 5Radiotherapy 4Cyclosporine 4Antilymphocyte Serum 4Busulfan 3fludarabine phosphate 2Therapeutics 2Mycophenolic Acid 2Methylprednisolone 2Filgrastim 2Cord Blood Stem Cell Transplantation 2thymoglobulin 1sargramostim 1Whole-Body Irradiation 1Voriconazole 1Thalidomide 1Polymerase Chain Reaction 1Physical Therapy Modalities 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Melphalan 1Interferon alpha-2 1Immunoenzyme Techniques 1Health 1Fluconazole 1Flow Cytometry 1Fibroblast Growth Factor 7 1Etoposide 1Dexamethasone 1Bronchoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Graft vs Host Disease × Thalidomide × Clear all
NCT00023530 2016-02-18

Blood and Marrow Transplant Clinical Research Network

National Heart, Lung, and Blood Institute (NHLBI)

Phase NA Completed
MyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hematologic Diseases, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡